0001104659-24-034034.txt : 20240313
0001104659-24-034034.hdr.sgml : 20240313
20240313180737
ACCESSION NUMBER: 0001104659-24-034034
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240311
FILED AS OF DATE: 20240313
DATE AS OF CHANGE: 20240313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kauffman Michael
CENTRAL INDEX KEY: 0001364719
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35403
FILM NUMBER: 24747278
MAIL ADDRESS:
STREET 1: C/O KARYOPHARM THERAPEUTICS INC.
STREET 2: 85 WELLS AVENUE, SECOND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Verastem, Inc.
CENTRAL INDEX KEY: 0001526119
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 273269467
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 117 KENDRICK STREET
STREET 2: SUITE 500
CITY: NEEDHAM
STATE: MA
ZIP: 02494
BUSINESS PHONE: (781) 292-4200
MAIL ADDRESS:
STREET 1: 117 KENDRICK STREET
STREET 2: SUITE 500
CITY: NEEDHAM
STATE: MA
ZIP: 02494
4
1
tm248737-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-03-11
0
0001526119
Verastem, Inc.
VSTM
0001364719
Kauffman Michael
C/O VERASTEM, INC.,
117 KENDRICK ST., SUITE 500
NEEDHAM
MA
02494
1
0
0
0
0
Stock Option (right to buy)
120.84
2024-03-11
4
D
0
2083
D
2024-06-10
Common Stock
2083
0
D
Stock Option (right to buy)
95.88
2024-03-11
4
D
0
1497
D
2025-06-11
Common Stock
1497
0
D
Stock Option (right to buy)
16.44
2024-03-11
4
D
0
2083
D
2026-06-13
Common Stock
2083
0
D
Stock Option (right to buy)
25.08
2024-03-11
4
D
0
2083
D
2027-06-13
Common Stock
2083
0
D
Stock Option (right to buy)
67.08
2024-03-11
4
D
0
2083
D
2028-06-11
Common Stock
2083
0
D
Stock Option (right to buy)
21.72
2024-03-11
4
D
0
2083
D
2029-06-21
Common Stock
2083
0
D
Stock Option (right to buy)
21.24
2024-03-11
4
D
0
2083
D
2030-06-16
Common Stock
2083
0
D
Stock Option (right to buy)
49.92
2024-03-11
4
D
0
2083
D
2031-06-28
Common Stock
2083
0
D
Stock Option (right to buy)
11.44
2024-03-11
4
A
0
16078
A
2034-03-11
Common Stock
16078
16078
D
On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.
The canceled stock option was granted on June 10, 2014 and provided for vesting in twelve equal monthly installments from June 10, 2014 until June 10, 2015.
The canceled stock option was granted on June 12, 2015 and provided for vesting in twelve monthly installments through June 12, 2016, with the first monthly installment vesting on July 12, 2015.
The canceled stock option was granted on June 14, 2016 and provided for vesting in twelve monthly installments through June 14, 2017, with the first monthly installment vesting on July 14, 2016.
The canceled stock option was granted on June 13, 2017 and provided for vesting in twelve monthly installments through June 13, 2018, with the first monthly installment vesting on July 13, 2017.
The canceled stock option was granted on June 21, 2018 and provided for vesting in twelve equal monthly installments beginning on July 11, 2018 ending on June 11, 2019.
The canceled stock option was granted on June 21, 2019 and provided for vesting in twelve equal monthly installments beginning on July 21, 2019 and ending on June 21, 2020.
The canceled stock option was granted on June 16, 2020 and provided for vesting in twelve equal monthly installments beginning on June 30, 2020 and ending on May 31, 2021.
The canceled stock option was granted on June 28, 2021 and provided for vesting in twelve equal month installments beginning on the on the last day of each month over a period from June 2021 to May 2022.
/s/ Daniel Calkins, Attorney in Fact
2024-03-13